Media Center

There are a number of challenges facing the field in 2020: developing new therapies with manufacturing in mind, managing public expectations, understanding changing regulatory frameworks, and finding investors who understand the importance of manufacturing in the value of a therapy. The Medicine Maker has explored the ingenious solutions emerging to take cell and gene therapy to the next level.

For more articles and information  from the Medicine Maker visit- https://themedicinemaker.com/manufacture/advanced-medicine

Find out who you can expect to meet onsite at the Patient Centric Cell Therapy Supply Chain Summit

For a copy sent to your inbox please email enquiryiqpc@iqpc.com

Download our Dear Boss Letter to gain a framework for articulating the value of attending Patient Centric Cell Therapy Supply Chain Summit 2020.

Fully customizable, our "justification letter" also includes an interactive attendee ROI calculator to help you build your case to attend.

For a hard copy to be sent to your inbox please email enquiryiqpc@iqpc.com

Process Considerations for Cryogenic Shipping

• Craig Vermeyen, Senior Manager, Packaging Engineering, Kite (A Gilead Company)

How blockchain unlocks the nextgeneration pharma supply chain

• Ben Taylor, CEO, LedgerDomain Member, Clinical Supply Blockchain Working Group  

Temperature-Controlled Blockchain: a Key Component of the Extended Patient Centric Supply Chain  

• Hector Rodriguez, Oracle Health & Life Sciences, Industry Vice President and Executive Director

C-Suite Perspective on Top Business Challenges

• Shital Parikh Mars, CEO, Progressive Care, Inc.